Valuation: Electromed, Inc.

Market Cap 376M 329M 302M 282M 534M 35.82B 542M 3.63B 1.41B 17.61B 1.41B 1.38B 60.67B P/E 2026 *
37.3x
P/E 2027 * 30.7x
Enterprise Value 376M 329M 302M 282M 534M 35.82B 542M 3.63B 1.41B 17.61B 1.41B 1.38B 60.67B EV / Sales 2026 *
5.11x
EV / Sales 2027 * 4.5x
Free-Float
82.79%
Yield 2026 *
-
Yield 2027 * -
1 day+3.09%
1 week+9.58%
Current month+7.40%
1 month+27.43%
3 months+95.06%
6 months+65.86%
Current year+56.01%
1 week 40.77
Extreme 40.7715
45.49
1 month 35.61
Extreme 35.61
45.49
Current year 23.01
Extreme 23.01
45.49
1 year 17.73
Extreme 17.73
45.49
3 years 8.8
Extreme 8.8
45.49
5 years 8.75
Extreme 8.75
45.49
10 years 3.38
Extreme 3.38
45.49
Manager TitleAgeSince
Chief Executive Officer 61 30/06/2023
Director of Finance/CFO 44 13/11/2022
Compliance Officer - 31/08/2023
Director TitleAgeSince
Chairman 69 30/06/2023
Director/Board Member 76 20/11/2014
Director/Board Member 57 14/08/2019
Date Insider Type Main position Quantity % Market Cap.
06-29Tax

Chief Financial Officer

-674 0.0081%
06-07Fiscal year

Chief Executive Officer

29,100 0.3514%
06-03Fiscal year

Chief Financial Officer

31,003 0.3744%
Change 5-day change 1-year change 3-year change Capi.($)
+3.09%+9.58%+118.62%+326.17% 376M
+1.97%+2.03%+21.92%+0.83% 195B
+5.87%+5.27%-21.76%+26.78% 151B
+2.17%+0.89%-2.59%-16.42% 140B
+4.83%+2.06%-56.73%-15.69% 67.09B
+2.59%+3.95%+22.89%+3.15% 54.34B
+0.03%+2.19%-25.48%-31.00% 44.63B
+0.31%+1.30%+8.30%+43.25% 37.24B
-2.02%-3.91%+7.67%+9.53% 36.91B
+4.24%+4.66%-18.42%-2.34% 30.24B
Average +2.31%+3.81%+5.44%+34.43% 75.63B
Weighted average by Cap. +2.78%+3.44%-3.97%+2.18%

Financials

2026 *2027 *
Net sales 73.6M 64.34M 59.13M 55.12M 105M 7.01B 106M 710M 276M 3.44B 276M 270M 11.87B 83.6M 73.08M 67.16M 62.6M 119M 7.96B 121M 806M 313M 3.91B 314M 307M 13.48B
Net income 10.53M 9.21M 8.46M 7.89M 14.96M 1B 15.19M 102M 39.49M 493M 39.54M 38.69M 1.7B 12.83M 11.22M 10.31M 9.61M 18.23M 1.22B 18.5M 124M 48.12M 601M 48.17M 47.14M 2.07B
Net Debt - -
Logo Electromed, Inc.
Electromed, Inc. develops, manufactures, markets and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System, to patients with compromised pulmonary function. It applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The SmartVest Clearway System consists of an inflatable therapy garment, a programmable air pulse generator and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall. The SmartVest Clearway is designed for comfort and convenience, so patients can readily fit therapy into their daily routines. The SmartVest System is primarily prescribed for patients with bronchiectasis, cystic fibrosis, and neuromuscular conditions such as cerebral palsy and amyotrophic lateral sclerosis. It also markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to health care providers in the acute care setting.
Employees
179
Date Price Change Volume
02/07/26 US$45.43 +3.09% 95,952
01/07/26 US$44.07 +4.18% 121,702
30/06/26 US$42.30 +0.17% 160,430
29/06/26 US$42.23 +1.86% 97,113
26/06/26 US$41.46 +3.52% 201,127
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
45.43USD
Average target price
40.33USD
Spread / Average Target
-11.22%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ELMD Stock